Already a member? Sign in
Nevirapine is a non-nucleoside reverse transcriptase inhibitors (NNRTIs), used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| HIV (Human Immunodeficiency Virus) | 76 | 18 |
|
|
|
|
|
| Other | 2 | 2 |
|
|
|||
| Support immune health | 1 | 1 |
|
||||
| Participate in clinical trial | 1 | 1 |
|
See all 81 patients currently taking Nevirapine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Nevirapine
| Depressed mood | 1 | |
|---|---|---|
| Fatigue | 1 | |
| Malaise | 1 | |
| Nausea and vomiting | 1 | |
| Flu like symptoms | 1 | |
| Diarrhea intermittent | 1 | |
| See all 11 reported side effects ▼ | ||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 5 | ||
| Did not seem to work | 2 | ||
| Expense | 2 | ||
| Doctor's advice | 2 | ||
| Other | 1 | ||
| Change in health plan coverage | 1 |
Adherence
Taking treatment as prescribed
Adherence of Nevirapine
Always |
16 | 76% |
|
|---|---|---|---|
Usually |
2 | 10% |
|
Sometimes |
1 | 5% |
|
Never |
2 | 10% |
|
Burden
Difficulty being on treatment
Burden of Nevirapine
Very |
5 | 24% |
|
|---|---|---|---|
Somewhat |
2 | 10% |
|
A little |
1 | 5% |
|
Not at all |
13 | 62% |
|
Cost
Paid out of pocket
Cost of Nevirapine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 9% |
|
< $25 |
10 | 91% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 09, 2012.